RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
PharmaSGP Holding Stock

PharmaSGP Holding ROA 2024

PharmaSGP Holding ROA

0.12

Ticker

PSG.DE

ISIN

DE000A2P4LJ5

WKN

A2P4LJ

In 2024, PharmaSGP Holding's return on assets (ROA) was 0.12, a 34.88% increase from the 0.09 ROA in the previous year.

PharmaSGP Holding Aktienanalyse

What does PharmaSGP Holding do?

PharmaSGP Holding SE is a leading European company specializing in the marketing of over-the-counter and natural pharmaceuticals. The company was founded in 2009 and is headquartered in Gräfelfing near Munich. The history of PharmaSGP began with the vision of founder and CEO Alexander Kurz, who believed that many people were looking for natural alternatives to pharmaceuticals. Kurz founded PharmaSGP with the goal of developing natural health products that help people improve their health and well-being. PharmaSGP's business model focuses on the marketing of over-the-counter and natural pharmaceuticals through pharmacies, drugstores, and online sales. The company has a strong presence in Europe and is also expanding into other regions worldwide. PharmaSGP is divided into three divisions: Consumer Healthcare, Medical Devices, and Healthcare Services. The Consumer Healthcare division offers natural health products and dietary supplements targeting consumers. The company has developed a wide range of products specifically tailored to the needs of people at different stages of life, from pregnancy and breastfeeding to old age. In the field of medical devices, PharmaSGP focuses on the development and marketing of innovative medical devices and technologies tailored to the needs of healthcare professionals. The company has developed a range of medical devices such as medication dispensers or blood glucose meters to facilitate disease treatment. In the Healthcare Services division, the company also offers services such as medical consulting and patient management. This involves holistic patient care, offering various services to ensure effective and comprehensive treatment. PharmaSGP also has an impressive range of products covering various health areas. There are products for dietary supplementation, sleep support, pain therapy, and cold relief, to name just a few. One of PharmaSGP's most well-known products is Yokebe, a natural meal replacement that can help reduce weight. The company is committed to ensuring the quality of its products and therefore works closely with scientists and healthcare professionals to ensure that all products are based on current scientific knowledge and studies. In summary, PharmaSGP is an innovative company focused on the marketing of natural and over-the-counter pharmaceuticals. It has developed a wide range of products and services specifically tailored to the needs of consumers and healthcare professionals. The company is committed to continuously improving the quality of its products and services and works closely with scientists and healthcare professionals to ensure comprehensive patient care. PharmaSGP Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding PharmaSGP Holding's Return on Assets (ROA)

PharmaSGP Holding's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing PharmaSGP Holding's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider PharmaSGP Holding's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in PharmaSGP Holding’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about PharmaSGP Holding stock

What is the Return on Assets (ROA) of PharmaSGP Holding this year?

The Return on Assets (ROA) of PharmaSGP Holding is 0.12 undefined this year.

What was the ROA of PharmaSGP Holding compared to the previous year?

The ROA of PharmaSGP Holding has increased by 34.88% compared to the previous year.

What consequences do high ROA have for investors of PharmaSGP Holding?

A high ROA is advantageous for investors of PharmaSGP Holding, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in PharmaSGP Holding?

A low ROA can be unfavorable for investors of PharmaSGP Holding as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of PharmaSGP Holding affect the company?

An increase in ROA of PharmaSGP Holding can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of PharmaSGP Holding impact the company?

A reduction in the ROA of PharmaSGP Holding can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of PharmaSGP Holding?

Some factors that can influence the ROA of PharmaSGP Holding include revenue, operating costs, asset structure, and industry average.

Why is the ROA of PharmaSGP Holding important for investors?

The ROA of PharmaSGP Holding is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can PharmaSGP Holding take to improve ROA?

To improve ROA, PharmaSGP Holding can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does PharmaSGP Holding pay?

Over the past 12 months, PharmaSGP Holding paid a dividend of 0.49 EUR . This corresponds to a dividend yield of about 2.02 %. For the coming 12 months, PharmaSGP Holding is expected to pay a dividend of 0.59 EUR.

What is the dividend yield of PharmaSGP Holding?

The current dividend yield of PharmaSGP Holding is 2.02 %.

When does PharmaSGP Holding pay dividends?

PharmaSGP Holding pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of PharmaSGP Holding?

PharmaSGP Holding paid dividends every year for the past 0 years.

What is the dividend of PharmaSGP Holding?

For the upcoming 12 months, dividends amounting to 0.59 EUR are expected. This corresponds to a dividend yield of 2.45 %.

In which sector is PharmaSGP Holding located?

PharmaSGP Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von PharmaSGP Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of PharmaSGP Holding from 7/1/2024 amounting to 1.36 EUR, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did PharmaSGP Holding pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of PharmaSGP Holding in the year 2023?

In the year 2023, PharmaSGP Holding distributed 0.45 EUR as dividends.

In which currency does PharmaSGP Holding pay out the dividend?

The dividends of PharmaSGP Holding are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von PharmaSGP Holding

Our stock analysis for PharmaSGP Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PharmaSGP Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.